Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients

Journal of the National Cancer Institute

Volumn 95, Issue 22, 2003, Pages 1718-1721

  Kutler, David I ^a,c   Wreesmann, Volkert B ^a   Goberdhan, Andy ^a   Ben Porat, Leah ^b   Satagopan, Jaya ^b   Ngai, Ivan ^a   Huvos, Andrew G ^b   Giampietro, Philip ^c   Levran, Orna ^c   Pujara, Kanan ^c   Diotti, Rafaella ^c   Carlson, Diane ^b   Huryn, Laryssa A ^a   Auerbach, Arleen D ^c   Singh, Bhuvanesh ^a,c  

^a Division of Head and Neck Surgery   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BONE MARROW DEPRESSION; CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONGENITAL MALFORMATION; CONTROLLED STUDY; DNA EXTRACTION; ETHNIC DIFFERENCE; FANCONI ANEMIA; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SCREENING; HOMOZYGOSITY; HUMAN; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; WART VIRUS;

EID: 0345720836     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djg091     Document Type: Article

References (29)

1. Auerbach AD, Buchwald M, Joenje H. Fanconi anemia. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. 2nd ed. New York (NY): McGraw-Hill; 2002. p. 317-32.
2. Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 2003;101: 1249-56.
3. Alter BP. Cancer in Fanconi anemia, 1927-2001. Cancer 2003;97:425-40.
4. Kutler DI, Auerbach AD, Satagopan J, Giampietro PF, Batish SD, Huvos AG, et al. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg 2003;129:106-12.
5. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003;101:822-6.
6. Ries LA. Rates. In: Harras A, editor. Cancer: rates and risks. Washington (DC): National Institutes of Health; 1996. p. 9-55.
7. Maier H, Sennewald E, Heller GF, Weidauer H. Chronic alcohol consumption-the key risk factor for pharyngeal cancer. Otolaryngol Head Neck Surg 1994;110:168-73.
8. Frisch M, Biggar RJ. Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas. Lancet 1999;354:1442-3.
9. Gillison ML, Shah KV. Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol 2001;13:183-8.
10. Fouret P, Monceaux G, Temam S, Lacourreye L, St. Guily JL. Human papillomavirus in head and neck squamous cell carcinomas in nonsomkers. Arch Otolaryngol Head Neck Surg 1997;123:513-6.
11. Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilczynski SP. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 1997;79:595-604.
12. Hildesheim A, Han CL, Brinton LA, Kurman RJ, Schiller JT. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study. Obstet Gynecol 1997; 90:748-54.
13. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus type-16 and type-18 E6 proteins with p53. Science 1990; 248:76-9.
14. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus type-16 and type-18 promotes the degradation of P53. Cell 1990;63:1129-36.
15. Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, et al. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci U S A 1993;90: 3988-92.
16. Jones DL, Munger K. Analysis of the p53-mediated G(1) growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J Virol 1997;71:2905-12.
17. Hording U, Junge J, Daugaard S, Lundvall F, Poulsen H, Bock JE. Vulvar squamous cell carcinoma and papillomaviruses: indications for two different etiologies. Gynecol Oncol 1994;52:241-6.
18. Specht K, Richter T, Muller U, Walch A, Werner M, Hofler H. Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am J Pathol 2001;158:419-29.
19. Lehmann U, Bock O, Glockner S, Kreipe H. Quantitative molecular analysis of laser-microdissected paraffin-embedded human tissues. Pathobiology 2000;68:202-8.
20. Lehmann U, Glockner S, Kleeberger W, Feist H, von Wasielewski R, Kreipe H. Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction. Am J Pathol 2000; 156:1855-64.
21. Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, Holm R, et al. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol 1996;34:2095-100.
22. Ha PK, Pai SI, Westra WH, Gillison ML, Tong BC, Sidransky D, et al. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res 2002;8:1203-9.
23. Singh B, Reddy PG, Goberdhan A, Walsh C, Dao S, Ngai I, et al. p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas. Genes Dev 2002;16:984-93.
24. Scheffner M, Munger K, Byrne JC, Howley PM. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci U S A 1991;88:5523-7.
25. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998;393:229-34.
26. Makni H, Franco EL, Kaiano J, Villa LL, Labrecque S, Dudley R, et al. p53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation. Int J Cancer 2000;87:528-33.
27. Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D. Head and neck cancer in non-smokers: a distinct clinical and molecular entity. Laryngoscope 1999;109:1544-51.
28. Majewski S, Jablonska S, Orth G. Epidermodysplasia verruciformis. Immunological and nonimmunological surveillance mechanisms: role in tumor progression. Clin Dermatol 1997;15:321-34.
29. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 2002;32:579-81.